Success Metrics

Clinical Success Rate

62.5%

Based on 5 completed trials

Completion Rate

63%(5/8)

Active Trials

0(0%)

Results Posted

140%(7 trials)

Terminated

3(38%)

Phase Distribution

Ph phase_3

50%

Ph phase_1

25%

Ph phase_2

13%

Ph phase_4

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

2(25.0%)

Phase 2Efficacy & side effects

1(12.5%)

Phase 3Large-scale testing

4(50.0%)

Phase 4Post-market surveillance

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(3)

Detailed Status

Completed5

Terminated3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

62.5%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (25.0%)

Phase 21 (12.5%)

Phase 34 (50.0%)

Phase 41 (12.5%)

Trials by Status

completed563%

terminated338%

Recent Activity

0 active trials

Showing 5 of 8

completedphase_1

Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes

NCT01409239

completedphase_3

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma

NCT00139659

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT05441631Phase 1

Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

Completed

NCT00812253Phase 2

Intensive Glycemic Control for Congestive Heart Failure Exacerbation

Completed

NCT00812487Phase 1

Glycemic Control and Variability for Congestive Heart Failure Exacerbation

Completed

NCT01409239Phase 4

Effect of Glycemic Variability on Autonomic Tone in Hospitalized Patients With Type 2 Diabetes

Completed

NCT00139659Phase 3

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma

Completed

NCT00136916Phase 3

Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes

Terminated

NCT00137046Phase 3

Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes

Terminated

NCT00138671Phase 3

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Terminated

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8